Progression of salivary gland dysfunction in patients with Sjögren's syndrome

Annals of the Rheumatic Diseases

Volumn 66, Issue 1, 2007, Pages 107-112

  Pijpe, J ^a   Kalk, W W I ^a   Bootsma, H ^a   Spijkervet, F K L ^a   Kallenberg, C G M ^a   Vissink, A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HYDROXYCHLOROQUINE; IMMUNOMODULATING AGENT; LEFLUNOMIDE; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE DURATION; DRUG USE; DYSPHAGIA; FEMALE; FLOW RATE; FOLLOW UP; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PAROTID GLAND; PRIORITY JOURNAL; SALIVA ANALYSIS; SALIVARY GLAND DISEASE; SALIVATION; SJOEGREN SYNDROME;

ADULT; AGED; CASE-CONTROL STUDIES; CHLORIDES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PAROTID GLAND; SALIVA; SALIVARY GLANDS; SALIVATION; SECRETORY RATE; SJOGREN'S SYNDROME; SODIUM; SUBLINGUAL GLAND; SUBMANDIBULAR GLAND; TIME FACTORS;

EID: 33846024307     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2006.052647     Document Type: Article

References (27)

1. Mignogna MD, Fedele S, Russo LL, Lo Muzio L, Wolff A. Sjögren's syndrome: the diagnostic potential of early oral manifestations preceding hyposalivation/xerostomia. J Oral Pathol Med 2005;34:1-6.
2. Thorn JJ, Prause JU, Oxholm P. Sialochemistry in Sjögren's syndrome: a review J Oral Pathol Med 1989;18:457-68.
3. Kalk WWI, Vissink A, Spijkervet FKL, Bootsma H, Kallenberg CGM, Nieuw Amerongen AV. Sialometry and sialochemistry: diagnostic tools for Sjögren's syndrome. Ann Rheum Dis 2001;60:1110-16.
4. Veerman ECI, Van den Keybus PA, Vissink A, Nieuw Amerongen AV. Human glandular salivas: their separate collection and analysis. Eur J Oral Sci 1990;104:346-52.
5. Vitali C, Bombardieri S, Jonsson R, Mautsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
6. Kalk WWI, Vissink A, Stegenga B, Bootsma H, Nieuw Amerongen AV, Kallenberg CGM. Sialometry and sialochemistry: a non-invasive approach for diagnosing Sjögren's syndrome. Ann Rheum Dis 2002;61:137-44.
7. Atkinson JC, Travis WD, Pillemer SR, Bermudez D, Wolff A, Fox PC. Major salivary gland function in primary Sjögren's syndrome and its relationship to clinical features. J Rheumatol 1990;17:318-22.
8. Carpenter GH, Proctor GB, Pankhurst CL, O'Donohue J, Scott D, Hunnable MP. Sialochemical markers of salivary gland involvement with Sjögren's syndrome secondary to rheumatoid arthritis and primary biliary cirrhosis. J Oral Pathol Med 2000;29:452-9.
9. Lindvall AM, Jonsson R. The salivary gland component of Sjögren's syndrome: an evaluation of diagnostic methods. Oral Surg Oral Med Oral Pathol 1986;62:32-42.
10. Vissink A, Panders AK, Nauta JM, Ligeon EE, Nikkels PG, Kallenberg CGM. Applicability of saliva as a diagnostic fluid in Sjögren's syndrome. Ann N Y Acad Sci 1993;694:325-9.
11. Burlage FR, Pijpe J, Coppes RP, Hemels MEW, Meertens H, Canrinus A, et al. Variability of flow rate when collecting stimulated human parotid saliva. Eur J Oral Sci 2005;113:386-90.
12. Fox PC, Busch KA, Baum BJ. Subjective reports of xerostomia and objective measures of salivary gland performance. J Am Dent Assoc 1987;115:581-4.
13. Vissink A, Spijkervet FKL, Van Nieuw AAV. Aging and saliva: a review of the literature. Spec Care Dentist 1996;16:95-103.
14. Fox PC, Datiles M, Atkinson JC, Macynski AA, Scott J, Fletcher D, et al. Prednisone and piroxicam for treatment of primary Sjögren's syndrome. Clin Exp Rheumatol 1993;11:149-56.
15. Miyawaki S, Nishiyama S, Matoba K. Efficacy of low-dose prednisolone maintenance for saliva production and serological abnormalities in patients with primary Sjögren's syndrome. Intern Med 1999;38:938-43.
16. Zandbelt MM, Van den Hoogen FH, De Wilde PC, Van den Berg PJ, Schneider HG, Van de Putte LB. Reversibility of histological and immunohistological abnormalities in sublabial salivary gland biopsy specimens following treatment with corticosteroids in Sjögren's syndrome. Ann Rheum Dis 2001;60:511-13.
17. Gannot G, Lancaster HE, Fox PC. Clinical course of primary Sjögren's syndrome: salivary, oral, and serologic aspects. J Rheumatol 2000;27:1905-9.
18. Haga HJ. Clinical and immunological factors associated with low lacrimal and salivary flow rate in patients with primary Sjögren's syndrome. J Rheumatol 2002;29:305-8.
19. Jonsson R, Kroneld U, Backman K, Magnusson B, Tarkowski A. Progression of sialadenitis in Sjögren's syndrome. Br J Rheumatol 1993;32:578-81.
20. Kruize AA, Hene RJ, Van der Heide A, Bodeutsch C, De Wilde PC, Van Bijsterveld OP, et al. Long-term followup of patients with Sjögren's syndrome. Arthritis Rheum 1996;39:297-303.
21. Leroy JP, Pennec YL, Soulier C, Berthelot JM, Letoux G, Youinou P. Follow up study of labial salivary gland lesions in primary Sjögren's syndrome. Ann Rheum Dis 1992;51:777-80.
22. Pertovaara M, Pukkala E, Laippala P, Miettinen A, Pasternack A. A longitudinal cohort study of Finnish patients with primary Sjögren's syndrome: clinical, immunological, and epidemiological aspects. Ann Rheum Dis 2001;60:467-72.
23. Theander E, Andersson SI, Manthorpe R, Jacobsson LT. Proposed core set of outcome measures in patients with primary Sjögren's syndrome: 5 year follow up. J Rheumatol 2005;32:1495-502.
24. Pedersen AM, Reibel J, Nordgarden H, Bergem HO, Jensen JL, Nauntofte B. Primary Sjögren's syndrome: salivary gland function and clinical oral findings. Oral Dis 1999;5:128-38.
25. Pedersen AM, Bardow A, Nauntofte B. Salivary changes and dental caries as potential oral markers of autoimmune salivary gland dysfunction in primary Sjögren's syndrome. BMC Clin Pathol 2005;5:4.
26. Pijpe J, Van Imhoff GW, Spijkervet FKL, Roodenburg JLN, Wolbink GJ, Mansour K, et al. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study. Arthritis Rheum 2005;52:2740-50.
27. Halse AK, Marthinussen MC, Wahren-Herlenius M, Jonsson R. Isotype distribution of anti-Ro/SS-A and anti-La/SS-B antibodies in plasma and saliva of patients with Sjögren's syndrome. Scand J Rheumatol 2000;29:13-19.